BioInvent International AB (STU:BIX) Accounts Payable & Accrued Expense : €0.00 Mil (As of Mar. 2025)

View and export this data going back to 2013. Start your Free Trial

What is BioInvent International AB Accounts Payable & Accrued Expense?

BioInvent International AB's quarterly accounts payable & accrued expense increased from Sep. 2024 (€0.00 Mil) to Dec. 2024 (€4.27 Mil) but then declined from Dec. 2024 (€4.27 Mil) to Mar. 2025 (€0.00 Mil).

BioInvent International AB's annual accounts payable & accrued expense declined from Dec. 2022 (€3.76 Mil) to Dec. 2023 (€2.61 Mil) but then increased from Dec. 2023 (€2.61 Mil) to Dec. 2024 (€4.27 Mil).

BioInvent International AB Accounts Payable & Accrued Expense Historical Data

The historical data trend for BioInvent International AB's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BioInvent International AB Accounts Payable & Accrued Expense Chart

BioInvent International AB Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Accounts Payable & Accrued Expense

Get a 7-Day Free Trial

1.66

1.92

3.76

2.61

4.27

BioInvent International AB Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial															-	-	-	4.27	-

BioInvent International AB Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

BioInvent International AB Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BioInvent International AB (STU:BIX) » Definitions » Accounts Payable & Accrued Expense

Comparable Companies

Traded in Other Exchanges

BINV:Sweden 0H22:UK BIX0:Germany

Address

Ideongatan 1, Lund, SWE, SE-223 70

Website

https://www.bioinvent.com

BioInvent International AB is a clinical-stage biotech company. It discovers and develops novel and first-in-class immuno-modulatory antibodies for cancer therapy, with currently four drug candidates in five ongoing clinical programs in Phase 1/2 trials for the treatment of hematological cancer and solid tumors, respectively. The company's validated, proprietary F.I.R.S.T technology platform identifies both targets and the antibodies that bind to them, generating many new drug candidates to fuel the company's clinical development pipeline and providing licensing and partnering opportunities. The company's pipeline portfolio comprises BI-1206, an antagonistic blocking antibody for the treatment of non-Hodgkin's lymphoma, and BI-1808 and BI-1910 (anti-TNFR2) for solid cancers.

BioInvent International AB Headlines

No Headlines